XORTX Therapeutics XRTX
NASDAQ XRTX
$1.70 0.00 (-0.28%)
As of: Sep 30, 2026 · 10:23 AM EDT

XORTX Therapeutics (XRTX) Debt Ratio (2022 - 2023)

Updated

XORTX Therapeutics' (XRTX) Debt Ratio stood at 0.01 in the quarter ended Mar 31, 2023, up 19.2% from the prior quarter.

Analysis

XORTX Therapeutics (XRTX) Debt Ratio (2022 - 2023) Analysis & Trends

Starting with the quarter ended Jun 30, 2022, XORTX Therapeutics' Debt Ratio history includes 4 quarters.

  • Per Business Quant, the preceding three quarters came in at 0.01 (quarter ended Dec 31, 2022), 0.01 (quarter ended Sep 30, 2022) and 0.01 (quarter ended Jun 30, 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 0.24
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 0.52
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 0.42
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 0.31
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 0.00
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 0.60
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 0.53
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 XORTX Therapeutics 1.62 Mn -1.68 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 0.01
Dec 31, 2022 0.01
Sep 30, 2022 0.01
Jun 30, 2022 0.01
API Access

XORTX Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=XRTX&period=max&api_key=YOUR_API_KEY